Authors:
Green, A
Brutti, G
Patterson, CC
Dahlquist, G
Soltesz, G
Green, A
Schober, E
Weets, I
Vandevalle, C
Gorus, F
Coeckelberghs, M
Du Caju, M
Christov, V
Tzaneva, V
Iotova, V
Roglic, G
Vavrinec, J
Olsen, BS
Svendsen, AJ
Kreutzfeldt, J
Lund, E
Poodar, T
Tuomilehto, J
Karvonen, M
Levy-Marchal, C
Czernichow, P
Doutreix, J
Giani, G
Neu, A
Bartsocas, C
Kassiou, K
Dacou-Voutetaki, C
Kafourou, AC
Al-Qadreh, A
Karagianni, C
Papazoglou, N
Soltesz, G
Thorsson, AV
Laron, Z
Gordon, O
Albag, Y
Shamis, I
Chiumello, G
Pozzilli, P
Visalli, N
Sebastiani, L
Marietti, G
Buzzetti, R
Songini, M
Casu, A
Marinaro, A
Ricciardi, R
Zedda, MA
Milia, A
Purrello, F
Arpi, M
Fichera, G
Mancuso, M
Lucenti, C
Brigis, G
Urbonaite, B
De Beaufort, C
Kocova, M
Reeser, M
Joner, G
Woznicka, D
Szybinski, Z
Jarosz-Chobot, P
Kinaiska, I
Abreu, S
Menezes, C
Pina, EA
Ionescu-Tirgoviste, C
Michalkova, D
Hlava, P
Mikulecky, M
Cernay, J
Krzisnik, C
Battelino, T
Bratina-Ursic, N
Goday, A
Dahlquist, G
Schonle, E
Patterson, C
Greenlees, R
Carson, D
Hadden, D
Bingley, P
Raymond, N
McKinney, P
Bodansky, H
Stephenson, C
Citation: A. Green et al., Variation and trends in incidence of childhood diabetes in Europe, LANCET, 355(9207), 2000, pp. 873-876
Authors:
Israel, E
Attie, KM
Bengtsson, BA
Blethen, SL
Blum, W
Cameron, F
Carel, JC
Carlsson, L
Chipman, JJ
Christiansen, JS
Clayton, P
Clemmons, DR
Cohen, P
Drop, S
Fujieda, K
Ghigo, E
Hintz, RL
Ho, K
Ilondo, MM
Jasper, H
Jesussek, B
Kappelgaard, AM
Laron, Z
Lippe, BM
Malozowski, S
Mullis, PE
de Munick-Keizer-Schrama, S
Nishi, Y
Parks, JS
Phelps, C
Ranke, M
Robinson, I
Rosenfeld, RG
Rose, S
Saenger, P
Saggese, G
Savage, M
Shalet, S
Sizonenko, PC
Strasburger, C
Tachibana, K
Tanaka, T
Thorner, MO
Wikland, KA
Zadik, Z
Citation: E. Israel et al., Consensus guidelines for the diagnosis and treatment of growth hormone (GH) deficiency in childhood and adolescence: Summary statement of the GH Research Society, J CLIN END, 85(11), 2000, pp. 3990-3993
Citation: Ms. Feinberg et al., Echocardiographic dimensions and function in adults with primary growth hormone resistance (Laron Syndrome), AM J CARD, 85(2), 2000, pp. 209-213
Citation: Z. Laron, Somatomedin-1 (recombinant insulin-like growth factor-1) - Clinical pharmacology and potential treatment of endocrine and metabolic disorders, BIODRUGS, 11(1), 1999, pp. 55-70
Citation: Ca. Benbassat et al., Changes in bone mineral density after discontinuation and early reinstitution of growth hormone (GH) in patients with childhood-onset GH deficiency, GROWTH H I, 9(5), 1999, pp. 290-295
Citation: Z. Laron et al., Serum insulin-like growth factor-I (IGF-I) levels during long-term IGF-I treatment of children and adults with primary GH resistance (Laron syndrome), J PED END M, 12(2), 1999, pp. 145-152
Citation: Z. Laron, Natural history of the classical form of primary growth hormone (GH) resistance (Laron syndrome), J PED END M, 12, 1999, pp. 231-249
Citation: Z. Laron, Commentary - The essential role of IGF-I: Lessons from the long-term studyand treatment of children and adults with Laron syndrome, J CLIN END, 84(12), 1999, pp. 4397-4404